This site is intended for Healthcare Professionals only.

Retrospective concessionary price for Isocarboxazid 10mg tablets

Date:

Share post:

The Department of Health and Social Care have retrospectively granted a concessionary price for Isocarboxazid 10mg tablets for the months of May and June 2021.

While the reimbursement price had previously been £217.75, a concessionary price of £249.10 has now been granted.

The NHS Business Services Authority confirmed that payment for the difference – £31.35 for every pack of 56 claimed – will be adjusted accordingly for the mentioned time period where contractors have submitted claims in those months. This adjustment will be paid on 31 December 2021 in the next Schedule of Payments.

The PSNC added that it sought the pricing adjustment for the tablets as the product did not fulfil Category A criteria in the May and June 2021 Drug Tariffs.

For the month of July 2021, a price concession was granted for Isocarboxazid 10mg tablets (56) at £249.10 and in August 2021 the product was moved to Category C based on Alliance Pharmaceuticals Ltd list price £249.10.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

#SaveOurPharmacies: NPA distributes fair funding campaign posters, stickers

The National Pharmacy Association (NPA) is distributing new campaign materials to pharmacies across England this week to empower...

Lake District pharmacy grapples with medicine shortages amidst growing crisis

79% of pharmacists fear for patient health according to Community Pharmacy England report A Lake District pharmacy is grappling...

Common antibiotic for whooping cough treatment ‘completely out of stock’ – Dr. Leyla Hannbeck

Whooping cough caused five infant deaths in the first quarter of 2024, according to UKHSA Pharmacists in the UK...

Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work

Nurses accounted for 52,000 of sick days, doctors for 3,500, both up since 2019 as per the Labour...